2024-11-18 2025-11-30 2025-11-30 false 16087053 Vending In The Valley Ltd 46330Wholesale of dairy products, eggs and edible oils and fats iso4217:GBP xbrli:pure 160870532024-11-18 160870532025-11-30 160870532024-11-18 2025-11-30 16087053bus:SmallEntities2024-11-18 2025-11-30 16087053bus:AuditExempt-NoAccountantsReport2024-11-18 2025-11-30 16087053bus:FullAccounts2024-11-18 2025-11-30 16087053core:WithinOneYear2025-11-30 16087053core:AfterOneYear2025-11-30 16087053core:WithinOneYear2024-11-18 2025-11-30 16087053core:AfterOneYear2024-11-18 2025-11-30 16087053core:CurrentFinancialInstruments2025-11-30 16087053core:Non-currentFinancialInstruments2025-11-30 16087053core:CurrentFinancialInstruments2024-11-18 2025-11-30 16087053core:Non-currentFinancialInstruments2024-11-18 2025-11-30 16087053core:LandBuildings2024-11-18 2025-11-30 16087053core:FurnitureFittings2024-11-18 2025-11-30 16087053core:OfficeEquipment2024-11-18 2025-11-30 16087053core:Vehicles2024-11-18 2025-11-30 16087053core:PlantMachinery2024-11-18 2025-11-30 16087053core:OtherPropertyPlantEquipment2024-11-18 2025-11-30 16087053core:LandBuildings2025-11-30 16087053core:PlantMachinery2025-11-30 16087053core:Vehicles2025-11-30 16087053core:FurnitureFittings2025-11-30 16087053core:OfficeEquipment2025-11-30 16087053core:OtherPropertyPlantEquipment2025-11-30 16087053core:Right-of-useAssets2024-11-18 2025-11-30 16087053core:Right-of-useAssets2025-11-30 16087053core:Goodwill2024-11-18 2025-11-30 16087053core:PatentsTrademarksLicencesConcessionsSimilar2024-11-18 2025-11-30 16087053core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-11-18 2025-11-30 16087053core:OtherResidualIntangibleAssets2024-11-18 2025-11-30 16087053core:Goodwill2025-11-30 16087053core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-11-30 16087053core:PatentsTrademarksLicencesConcessionsSimilar2025-11-30 16087053core:OtherResidualIntangibleAssets2025-11-30 16087053dpl:CostSales2024-11-18 2025-11-30 16087053dpl:AdministrativeExpenses2024-11-18 2025-11-30 16087053dpl:DistributionCosts2024-11-18 2025-11-3016087053core:ShareCapital2025-11-30 16087053core:SharePremium2025-11-30 16087053core:RevaluationReserve2025-11-30 16087053core:OtherReservesSubtotal2025-11-30 16087053core:ShareCapitalPreferenceShares2025-11-30 16087053core:CapitalRedemptionReserve2025-11-30 16087053core:OtherCapitalReserve2025-11-30 16087053core:RetainedEarningsAccumulatedLosses2025-11-3016087053core:ShareCapital2024-11-18 2025-11-30 16087053core:SharePremium2024-11-18 2025-11-30 16087053core:RevaluationReserve2024-11-18 2025-11-30 16087053core:OtherReservesSubtotal2024-11-18 2025-11-30 16087053core:RetainedEarningsAccumulatedLosses2024-11-18 2025-11-301608705312024-11-18 2025-11-30 1608705322024-11-18 2025-11-3016087053core:ShareCapital12024-11-18 2025-11-30 16087053core:ShareCapital22024-11-18 2025-11-3016087053core:SharePremium12024-11-18 2025-11-30 16087053core:SharePremium22024-11-18 2025-11-3016087053core:RevaluationReserve12024-11-18 2025-11-30 16087053core:RevaluationReserve22024-11-18 2025-11-3016087053core:RetainedEarningsAccumulatedLosses12024-11-18 2025-11-30 16087053core:RetainedEarningsAccumulatedLosses22024-11-18 2025-11-301608705312024-11-18 2025-11-3016087053core:Non-currentFinancialInstrumentscore:CostValuation2024-11-18 16087053core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3016087053core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-11-18 16087053core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-11-30 16087053core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-30 16087053core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-11-3016087053core:Non-currentFinancialInstruments2025-11-30 16087053core:Non-currentFinancialInstruments2024-11-1716087053bus:Director12024-11-18 2025-11-3016087053bus:Director22024-11-18 2025-11-3016087053bus:PrivateLimitedCompanyLtd2024-11-18 2025-11-30
Vending In The Valley Ltd
Unaudited Financial Statements
for the period ended 30 November 2025
Company registration number 16087053
(England and Wales)

Company Information

For the period 18 November 2024 to 30 November 2025
Directors Berry, Russell John
Berry, Naomi Michelle

Registered office 689 Burnley Road East
Rossendale
BB4 9PG

Registered number 16087053

Accountant H & M Ltd
The Four Columns
Broughton Hall Business Park
Skipton
BD23 3AE

Statement of Financial Position

As at 30 November 2025
Notes
2025
£
£
Fixed assets
Tangible assets
4
2,250
2,250
Current assets
Stocks
2,000
Cash at bank and in hand
1,629
3,629
Creditors
Amounts falling due within one year
5
(3,675)
(3,675)
Net current assets (liabilities)
(46)
Total assets less current liabilities
2,204
Provisions for liabilities
(428)
Net assets (liabilities)
1,776
Capital and reserves
Called up share capital
2
Profit and loss account
1,774
Total equity
1,776

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 8 July 2026 and are signed on its behalf by:

Berry, Russell John
Berry, Russell John
Director

Company registration number 16087053

Notes to the Financial Statements

For the period 18 November 2024 to 30 November 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods.


Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.


2.3. Deferred tax

Deferred taxation is provided on the liability method to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes.

 

Tax deferred or accelerated is accounted for in respect of all material timing differences, in particular accelerated capital allowances and revaluation gains on investment properties. All deferred tax is charged/(credited) to the Income Statement.

2.4. Tangible fixed assets and depreciation

Tangible assets are initially recorded at cost and are subsequently stated at cost less any accumulated depreciation and any accumulated impairment losses.

 

Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

 

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Rate
Method
%
Plant and machinery
10
Reducing balance

2.5. Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

2.6. Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

2.7. Financial instruments

The following assets and liabilities are classified as financial instruments - trade debtors, trade creditors, bank loans and directors' loans.

 

Bank loans are initially measured at the present value of future payments, discounted at a market rate of interest, and subsequently at amortised cost using the effective interest method.

 

Directors' loans (being repayable on demand), trade debtors and trade creditors are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

 

Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Income Statement.

3. Employees

The average number of employees during the year was 2.

4. Tangible fixed assets

Plant and machinery
Total
£
£
Cost
Additions
2,500
2,500
At 30 November 2025
2,500
2,500
Depreciation and impairment
Charge for the period
250
250
At 30 November 2025
250
250
Net book value
At 30 November 2025
2,250
2,250

5. Creditors due within one year

2025
£
Other creditors
3,631
Taxation and social security
44
Total
3,675